163 related articles for article (PubMed ID: 20820037)
1. Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study.
Romero-Gómez M; Jover M; Del Campo JA; Royo JL; Hoyas E; Galán JJ; Montoliu C; Baccaro E; Guevara M; Córdoba J; Soriano G; Navarro JM; Martínez-Sierra C; Grande L; Galindo A; Mira E; Mañes S; Ruiz A
Ann Intern Med; 2010 Sep; 153(5):281-8. PubMed ID: 20820037
[TBL] [Abstract][Full Text] [Related]
2. Validation study associating glutaminase promoter variations with hepatic encephalopathy in East Asian populations.
Ahn JM; Kim CH; Um SH; Kim KM; Kim TH; Yim SY; Choi HS; Kim ES; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2017 Apr; 32(4):901-907. PubMed ID: 27749985
[TBL] [Abstract][Full Text] [Related]
3. Hepatic encephalopathy in our genes?
Albrecht J
Ann Intern Med; 2010 Sep; 153(5):335-6. PubMed ID: 20820042
[No Abstract] [Full Text] [Related]
4. A genetic variant in the promoter of phosphate-activated glutaminase is associated with hepatic encephalopathy.
Mayer LB; Krawczyk M; Grünhage F; Lammert F; Stokes CS
J Intern Med; 2015 Sep; 278(3):313-22. PubMed ID: 25880019
[TBL] [Abstract][Full Text] [Related]
5. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
6. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
7. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.
Romero-Gómez M; Boza F; García-Valdecasas MS; García E; Aguilar-Reina J
Am J Gastroenterol; 2001 Sep; 96(9):2718-23. PubMed ID: 11569701
[TBL] [Abstract][Full Text] [Related]
8. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
9. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy.
Romero-Gómez M; Ramos-Guerrero R; Grande L; de Terán LC; Corpas R; Camacho I; Bautista JD
J Hepatol; 2004 Jul; 41(1):49-54. PubMed ID: 15246207
[TBL] [Abstract][Full Text] [Related]
10. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
Romero-Gómez M; Córdoba J; Jover R; del Olmo JA; Ramírez M; Rey R; de Madaria E; Montoliu C; Nuñez D; Flavia M; Compañy L; Rodrigo JM; Felipo V
Hepatology; 2007 Apr; 45(4):879-85. PubMed ID: 17393525
[TBL] [Abstract][Full Text] [Related]
11. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
Compañy L; Zapater P; Pérez-Mateo M; Jover R
Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits glutaminase activity and protects against hepatic encephalopathy.
Ampuero J; Ranchal I; Nuñez D; Díaz-Herrero Mdel M; Maraver M; del Campo JA; Rojas Á; Camacho I; Figueruela B; Bautista JD; Romero-Gómez M
PLoS One; 2012; 7(11):e49279. PubMed ID: 23166628
[TBL] [Abstract][Full Text] [Related]
13. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
[TBL] [Abstract][Full Text] [Related]
14. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease.
Stewart CA; Malinchoc M; Kim WR; Kamath PS
Liver Transpl; 2007 Oct; 13(10):1366-71. PubMed ID: 17520742
[TBL] [Abstract][Full Text] [Related]
15. Independent prognostic factors in patients with liver cirrhosis.
Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
[TBL] [Abstract][Full Text] [Related]
16. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
[TBL] [Abstract][Full Text] [Related]
17. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study.
Sörös P; Böttcher J; Weissenborn K; Selberg O; Müller MJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):606-10. PubMed ID: 18005013
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
Alvarez MA; Cirera I; Solà R; Bargalló A; Morillas RM; Planas R
J Clin Gastroenterol; 2011; 45(10):906-11. PubMed ID: 21814145
[TBL] [Abstract][Full Text] [Related]
19. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
[TBL] [Abstract][Full Text] [Related]
20. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
